Xing BC - Search Results

1

Autocrine Complement Inhibits IL10-Dependent T-cell-Mediated Antitumor Immunity to Promote Tumor Progression.

Wang Y, Sun SN, Liu Q, Yu YY, Guo J, Wang K, Xing BC, Zheng QF, Campa MJ, Patz EF Jr, Li SY, He YW. Wang Y, et al. Among authors: xing bc. Cancer Discov. 2016 Sep;6(9):1022-35. doi: 10.1158/2159-8290.CD-15-1412. Epub 2016 Jun 13. Cancer Discov. 2016. PMID: 27297552 Free PMC article.

2

[The effect of estrogen receptor level on the prognosis of the elderly breast cancer patients].

Xing BC, He L, Wang Y. Xing BC, et al. Zhonghua Zhong Liu Za Zhi. 1997 Sep;19(5):365-7. Zhonghua Zhong Liu Za Zhi. 1997. PMID: 10920918 Chinese.

3

[Expression of wild type and variant estrogen receptors in human hepatocellular carcinoma].

Xing BC, Wang JH, Wang Y, Hao CY, Huang XF, Wang Y. Xing BC, et al. Beijing Da Xue Xue Bao Yi Xue Ban. 2004 Dec;36(6):620-2. Beijing Da Xue Xue Bao Yi Xue Ban. 2004. PMID: 15605095 Free article. Chinese.

4

[Clinicopathological features of solid pseudopapillary tumor of the pancreas].

Wang K, Lu AP, Hao CY, Xing BC, Huang XF, Gao F, Ji JF. Wang K, et al. Among authors: xing bc. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006 Jun;28(3):418-20. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006. PMID: 16900648 Chinese.

5

[Clinical analysis of curative resection with hemihepatectomy for advanced hilar cholangiocarcinoma].

Sun Y, Wu ZY, Hao CY, Huang XF, Wang K, Bao Q, Qian HG, Xing BC. Sun Y, et al. Among authors: xing bc. Zhonghua Yi Xue Za Zhi. 2008 Feb 26;88(8):527-30. Zhonghua Yi Xue Za Zhi. 2008. PMID: 18649767 Chinese.

6

The properties of tumor-initiating cells from a hepatocellular carcinoma patient's primary and recurrent tumor.

Xu XL, Xing BC, Han HB, Zhao W, Hu MH, Xu ZL, Li JY, Xie Y, Gu J, Wang Y, Zhang ZQ. Xu XL, et al. Among authors: xing bc. Carcinogenesis. 2010 Feb;31(2):167-74. doi: 10.1093/carcin/bgp232. Epub 2009 Nov 6. Carcinogenesis. 2010. PMID: 19897602

7

Recurrent hepatocellular carcinoma cells with stem cell-like properties: possible targets for immunotherapy.

Xu X, Xing B, Hu M, Xu Z, Xie Y, Dai G, Gu J, Wang Y, Zhang Z. Xu X, et al. Cytotherapy. 2010 Apr;12(2):190-200. doi: 10.3109/14653240903390803. Cytotherapy. 2010. PMID: 19929456

8

1B50-1, a mAb raised against recurrent tumor cells, targets liver tumor-initiating cells by binding to the calcium channel α2δ1 subunit.

Zhao W, Wang L, Han H, Jin K, Lin N, Guo T, Chen Y, Cheng H, Lu F, Fang W, Wang Y, Xing B, Zhang Z. Zhao W, et al. Cancer Cell. 2013 Apr 15;23(4):541-56. doi: 10.1016/j.ccr.2013.02.025. Cancer Cell. 2013. PMID: 23597567 Free article.

9

[Surgical outcomes of second liver resections for recurrent hepatic metastases from colorectal cancer].

Liu W, Yan XL, Wang K, Bao Q, Sun Y, Wang HW, Jin KM, Xing BC. Liu W, et al. Among authors: xing bc. Zhonghua Yi Xue Za Zhi. 2013 Jul 23;93(28):2183-5. Zhonghua Yi Xue Za Zhi. 2013. PMID: 24169324 Chinese.

10

The outcome of liver resection and lymphadenectomy for hilar lymph node involvement in colorectal cancer liver metastases.

Liu W, Yan XL, Wang K, Bao Q, Sun Y, Xing BC. Liu W, et al. Among authors: xing bc. Int J Colorectal Dis. 2014 Jun;29(6):737-45. doi: 10.1007/s00384-014-1863-5. Epub 2014 Apr 18. Int J Colorectal Dis. 2014. PMID: 24743847

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters